Charles Conway
Overview
Charles Conway received an average of $2M in total compensation, including $320K in salary, at Biohaven Pharmaceutical Holding Co Ltd. between 2017 and 2018.
Source: SEC filings on April 11, 2019 and March 29, 2018.
Related executives
We found six more executives who work or worked at Biohaven Pharmaceutical Holding Co Ltd..
Vlad Coric
Biohaven Pharmaceutical Holding Co Ltd.
Chief Executive Officer
William Jones
Biohaven Pharmaceutical Holding Co Ltd.
Chief Commercial Officer of Migraine & Common Diseases
Kimberly Gentile
Biohaven Pharmaceutical Holding Co Ltd.
Senior Vice President, Clinical Operations
James Engelhart
Biohaven Pharmaceutical Holding Co Ltd.
Chief Financial Officer
Elyse Stock
Biohaven Pharmaceutical Holding Co Ltd.
Chief Medical Officer
John Tilton
Biohaven Pharmaceutical Holding Co Ltd.